AI Assistant
Blog
Pricing
Log In
Sign Up
MS disease activity in RESTORE: A randomized 24-week natalizumab treatment interruption study
Details
Cite
Export
Add to List
The content you want is available to Zendy users.
Already have an account? Click
here.
to sign in.